LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
Researchers will highlight new injection systems, wearable devices and testing services supporting high-viscosity biologics, ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to develop a 5.5 mL version of the BD Neopak XtraFlow Glass Prefillable ...
When BD unveiled a four-year, $1.2 billion upgrade to its drug delivery device manufacturing last year, the company teased plans for a new factory in Europe—and now it’s showing its hand. BD has ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果